News that combining chemotherapy with immunotherapy can help extend the lifespan of triple-negative breast cancer patients offers hope for those inflicted with this aggressive and hard-to-treat cancer.
It is a breakthrough for immunotherapy as breast cancer was thought to be unresponsive to the body's immune system.
Please subscribe or log in to continue reading the full article. Learn more about ST PREMIUM.
Enjoy unlimited access to ST's best work
- Exclusive stories and features on multiple devices
- In-depth analyses and opinion pieces
- ePaper and award-winning multimedia content